Buy Persistent Systems; target of Rs 940: HDFC Securities

HDFC Securities's research report on Persistent Systems

Persistent Systems (PSYS) posted strong rev growth (Alliance business-led comprising 32.1% of rev) and in-line operating performance. Revenue came at USD 123.6mn, 5.7/9.4% QoQ/YoY led by sharp growth in Alliance business (USD 11.3mn incremental QoQ with USD 6mn incremental from re-seller business).

Outlook

Expect rev/EPS at 10/17% CAGR over FY18-20E factoring USD rev growth at 8.6/12.2% and EBITDA% at 17.3/17.7% for FY19/20E, respectively. Maintain BUY with TP of Rs 940, at 17x FY20E-EPS.

For all recommendations report,�click here

Disclaimer:�The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Aug 1, 2018 04:39 pm

Top Safest Stocks To Watch For 2019

tags:CTL,DNOW,BTG,THQ, 303 Days to Go

Today in Brexit: With Italy dominating the headlines, a prominent anti-Brexit voice has a warning for the EU.

Less than two years after the Brexit vote, a new crisis is brewing in Europe.

Political turmoil in Italy rocked global markets yesterday, sparked by the prospect of anti-Europe, nationalist parties turning an election into a de facto referendum on Italy’s membership of the euro. Bond yields soared and the single currency fell. The British pound didn’t escape the selloff, falling to a six-month low against the dollar as investors sought the safest assets.

The turbulence, greeted with glee by some pro-Leave campaigners in Britain, recalls the chaos of the region’s debt crisis earlier this decade. It also serves as a timely reminder that the U.K.’s rocky process toward the exit isn’t quelling anti-EU movements across the continent, and that Europe’s problems do not stop at Brexit.

Top Safest Stocks To Watch For 2019: CenturyLink, Inc.(CTL)

Advisors' Opinion:

• [By Jason Hall]

  If you bought this time last year,�Centurylink Inc.�(NYSE:CTL)�and�Pattern Energy Group Inc.�(NASDAQ:PEGI)�haven't exactly been great investments, with share prices down 33% and 19%, respectively, while the�S&P 500�(SNPINDEX:^GSPC)�has gained 15%. Even when we factor in dividends, they lost investors money while the market delivered more than 17% in total returns.�

• [By Logan Wallace]

  Tredje AP fonden increased its holdings in shares of Centurylink Inc (NYSE:CTL) by 14.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 54,920 shares of the technology company’s stock after purchasing an additional 6,960 shares during the period. Tredje AP fonden’s holdings in Centurylink were worth $902,000 as of its most recent filing with the Securities and Exchange Commission.

• [By Jamal Carnette, CFA]

  CenturyLink (NYSE:CTL) has become a battleground stock among income investors. On one hand, the company's outsized dividend attracts yield-hungry investors. On the other, bearish investors cite increased pressure as more consumers cancel their landline telephone connections and cut the cord. Eventually, they argue, the company will be forced to cut its massive dividend and the share price will plummet.

Top Safest Stocks To Watch For 2019: NOW Inc.(DNOW)

Advisors' Opinion:

• [By Logan Wallace]

  National Oilwell Varco (NYSE: NOV) and DistributionNOW (NYSE:DNOW) are both oils/energy companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability.

• [By Shane Hupp]

  Shares of DistributionNOW (NYSE:DNOW) have been given an average rating of “Hold” by the fourteen ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $12.50.

• [By Logan Wallace]

  ValuEngine upgraded shares of DistributionNOW (NYSE:DNOW) from a strong sell rating to a sell rating in a report published on Friday.

  A number of other research analysts have also recently commented on the company. TheStreet upgraded DistributionNOW from a d+ rating to a c rating in a research note on Wednesday, May 16th. Stifel Nicolaus boosted their price objective on DistributionNOW from $13.00 to $15.00 and gave the stock a buy rating in a research note on Thursday, May 3rd. Cowen restated a market perform rating and set a $11.00 price objective (up previously from $9.00) on shares of DistributionNOW in a research note on Thursday, May 3rd. Susquehanna Bancshares set a $11.00 price objective on DistributionNOW and gave the stock a hold rating in a research note on Friday, April 13th. Finally, Credit Suisse Group restated a neutral rating and set a $10.00 price objective (down previously from $12.00) on shares of DistributionNOW in a research note on Tuesday, February 27th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of $13.00.

• [By Stephan Byrd]

  Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

  Get Alaska Air Group alerts: 68 percent of flight attendants say they have experienced sexual harassment on the job (finance.yahoo.com) ValuEngine Lowers Alaska Air Group (ALK) to Sell (americanbankingnews.com) Enamoring Five Stocks: Fitbit, Inc. (NYSE:FIT), Alaska Air Group, Inc. (NYSE:ALK), NOW Inc. (NYSE:DNOW), Leidos … (thestreetpoint.com) Average True Range under Trader’s Radar �� Alaska Air Group (NYSE: ALK) (stocktradingdesk.com) Undertaking Stocks: Incyte Corporation (NASDAQ:INCY), Alaska Air Group, Inc. (NYSE:ALK), Innoviva, Inc. (NASDAQ … (journalfinance.net)

  ALK has been the topic of a number of recent analyst reports. Morgan Stanley set a $78.00 price objective on Alaska Air Group and gave the stock a “buy” rating in a report on Friday, February 23rd. Stifel Nicolaus reaffirmed a “buy” rating and set a $105.00 price objective (down previously from $115.00) on shares of Alaska Air Group in a report on Wednesday, January 10th. Buckingham Research dropped their price objective on Alaska Air Group from $90.00 to $88.00 and set a “buy” rating on the stock in a report on Friday, January 26th. TheStreet lowered Alaska Air Group from a “b-” rating to a “c+” rating in a report on Monday, April 2nd. Finally, Barclays lowered Alaska Air Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $90.00 to $80.00 in a report on Wednesday, January 10th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $85.00.

Top Safest Stocks To Watch For 2019: B2Gold Corp(BTG)

Advisors' Opinion:

• [By Joseph Griffin]

  CIBC World Markets Inc. reduced its holdings in B2Gold Corp. (NYSEAMERICAN:BTG) (TSE:BTO) by 10.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 572,525 shares of the basic materials company’s stock after selling 64,714 shares during the period. CIBC World Markets Inc. owned approximately 0.06% of B2Gold worth $1,563,000 as of its most recent SEC filing.

• [By Stephan Byrd]

  Deutsche Bank reaffirmed their hold rating on shares of BTG (LON:BTG) in a report released on Wednesday.

  A number of other equities research analysts have also weighed in on BTG. Shore Capital upgraded BTG to a buy rating in a research report on Monday, March 26th. Peel Hunt restated a hold rating and set a GBX 700 ($9.32) price objective on shares of BTG in a research report on Wednesday, April 4th. JPMorgan Chase & Co. reduced their price objective on BTG from GBX 750 ($9.99) to GBX 680 ($9.05) and set a neutral rating on the stock in a research report on Friday, April 6th. Jefferies Financial Group boosted their price objective on BTG from GBX 775 ($10.32) to GBX 900 ($11.98) and gave the stock a buy rating in a research report on Tuesday, May 15th. Finally, Numis Securities reiterated a buy rating and issued a GBX 840 ($11.18) price target on shares of BTG in a research report on Tuesday, May 15th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of Buy and an average price target of GBX 745.83 ($9.93).

• [By Max Byerly]

  Here’s how other cryptocurrencies have performed during the last day:

  Get Bitgem alerts: Zcash (ZEC) traded 7.4% lower against the dollar and now trades at $243.26 or 0.03355620 BTC. Bitcoin Gold (BTG) traded 6% lower against the dollar and now trades at $41.47 or 0.00572057 BTC. Bitcoin Private (BTCP) traded up 1.3% against the dollar and now trades at $22.93 or 0.00316296 BTC. ZenCash (ZEN) traded 7.9% lower against the dollar and now trades at $29.94 or 0.00412942 BTC. ZClassic (ZCL) traded down 2.8% against the dollar and now trades at $11.31 or 0.00155982 BTC. BitcoinZ (BTCZ) traded 0.5% lower against the dollar and now trades at $0.0019 or 0.00000026 BTC. Hush (HUSH) traded 0.7% lower against the dollar and now trades at $0.83 or 0.00011450 BTC. Zero (ZER) traded up 13% against the dollar and now trades at $0.58 or 0.00008000 BTC. VoteCoin (VOT) traded 3.3% lower against the dollar and now trades at $0.0127 or 0.00000175 BTC. Bitcoin Interest (BCI) traded up 0.2% against the dollar and now trades at $4.83 or 0.00066692 BTC.

  Bitgem Profile

Top Safest Stocks To Watch For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors' Opinion:

• [By Ethan Ryder]

  Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Shares of Cleveland-Cliffs Inc. Pop 10% as Second-Quarter Earnings Surge

What happened?

Shares of Cleveland-Cliffs Inc. (NYSE:CLF), the largest and oldest iron-ore mining company in the U.S., were up 10% as of 3:14 p.m. EDT Friday after the company announced better than expected second-quarter results.

So what

The company reported consolidated revenues of $714 million, significantly better than the prior year's $471 million, and higher than analysts' estimates of $692.2 million, per analysts surveyed by investment research firm Zacks. Income from continuing operations jumped to $229 million, or $0.76 per diluted share, which was again a large improvement from the prior year's $84 million, or $0.28 per share, and well ahead of analysts' estimates calling for $0.56 per share, per Zacks. Another bright spot was a 16% increase in its U.S. iron-ore realized revenue rate.

Image source: Getty Images.

President and CEO Lourenco Goncalves said in a press release: "Our second quarter is a definitive statement about the new Cliffs and our earnings power. After almost four years of consistent execution of a well-designed and thoroughly implemented strategy, our company has become a very powerful cash-generating enterprise."

Now what

It's understandable that investors pushed the stock higher today. The second-quarter surge in earnings reflects an end, or near-end, to its multiyear transformation to get back to its roots as a supplier of high-grade iron units. Now that the company is focused on its roots, it expects to generate cash this year at a level it hasn't seen in years, and for that strong momentum to continue into 2019. Business is looking good, and today's 10% jump means investors are buying into its future potential.

Merck lowers some drug prices after Trump blasts

U.S. pharmaceutical giant Merck said Thursday that it will limit drug price increases and lower the price of several treatments.

Repeatedly slammed by President Donald Trump over drug prices,�the Kenilworth, N.J.-based company did not reference Trump in making the announcement.

But the company said it would "commit to not increase the average net price across our portfolio of products by more than inflation annually."

The "net price" is a cloudy figure�that can be difficult to assess because it may include the value of complex industry rebates and insurance reimbursements. Still,�the move reflects a step toward limiting the impact of drug costs on American consumers.

It also comes after Pfizer last week temporarily reversed price increases following criticism from Trump.

Pfizer, Merck and other drug companies have repeatedly been the subject of Trump's wrath.

"@Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!" Trump said on Twitter in August.

That Trump tweet came on the same day that Merck CEO Kenneth Frazier resigned from a presidential manufacturing council amid dissatisfaction with the president's response to white supremacist protests in Charlottesville, Va.

"America's leaders must honor our fundamental values by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all people are created equal," Frazier wrote at the time.

Merck said Thursday that its plans include a 60 percent price cut on�hepatitis C treatment Zepatier and a 10 percent cut on "several other medicines."

The company said it picked the products based on the "gap between list price and actual discounted (net) prices paid in the market, the contractual obligations under existing arrangements with payers, and the opportunity to broaden access to treatment."

More: Pfizer reverses drug price increases after President Trump blasted the company

More: President Trump slams Pfizer drug price increases, threatens action

More: Donald Trump vows to lower 'soaring' drug prices but abandons campaign idea

A bipartisan chorus of politicians, including Trump, have long criticized the drug industry over prices. But there's no indication of any significant pending policy action aimed at regulating prices, bolstering competition or some�other potential solution.

In May, Trump's administration issued a 44-page blueprint detailing his strategy to cut drug prices. But critics said it lacked aggressive maneuvers required to make a dent, such as potentially allowing Medicare to use its purchasing power to negotiate directly with drug companies.

"We will have tougher negotiation, more competition and much lower prices at the pharmacy counter," Trump said at the time. "And it will start to take effect very soon."

Merck said�Thursday, "Going forward, we will continue to evaluate our portfolio of products to look for opportunities to further reduce costs for patients and the health care system."

Follow USA TODAY reporter Nathan Bomey on Twitter @NathanBomey.

Top Biotech Stocks To Buy For 2019

tags:TLT,OPK,BBRY,

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Sun Pharmaceuticals' biologic approved for plaque psoriasis

Company: Sun Pharmaceuticals (OTCPK:SMPQY)

Therapy: Tildrakizumab-asmn

Disease: Plaque psoriasis

News: Indian pharma SMPQY announced that the FDA has approved their IL-23 antibody tildrakizumab-asmn for the treatment of moderate-to-severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy. This approval was based on the findings from two randomized, placebo-controlled trials showing significant clearance of plaque psoriasis compared with placebo.

Looking forward: With this approval, SMPQY enters a rather crowded field full of effective options for plaque psoriasis, including other therapies targeting interleukins, including the IL-23-directed antibody guselkumab. However, in spite of this rather heavy competition, SMPQY are likely going to be able to make a return on their investment with this approval, and the pie of plaque psoriasis is over $10 billion in the US alone.

Top Biotech Stocks To Buy For 2019: iShares 20+ Year Treasury Bond (TLT)

Advisors' Opinion:

• [By Shane Hupp]

  iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) announced a monthly dividend on Monday, July 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, July 3rd will be given a dividend of 0.2749 per share by the exchange traded fund on Monday, July 9th. This represents a $3.30 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, July 2nd.

• [By Stephan Byrd]

  NEXT Financial Group Inc raised its position in Ishares Lehman 20 Year (NASDAQ:TLT) by 30.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 10,785 shares of the exchange traded fund’s stock after acquiring an additional 2,489 shares during the period. NEXT Financial Group Inc’s holdings in Ishares Lehman 20 Year were worth $1,315,000 at the end of the most recent reporting period.

• [By WWW.GURUFOCUS.COM]

  For the details of Nationwide Fund Advisors's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Nationwide+Fund+Advisors

  These are the top 5 holdings of Nationwide Fund AdvisorsiShares Core MSCI Emerging Markets (IEMG) - 4,698,924 shares, 74.25% of the total portfolio. Shares added by 119.53%iShares 20+ Year Treasury Bond ETF (TLT) - 536,574 shares, 17.7% of the total portfolio. Shares added by 79.94%iShares iBoxx $ High Yield Corporate Bond (HYG) - 347,518 shares, 8.05% of the total portfolio. Shares reduced by 20.57%

Top Biotech Stocks To Buy For 2019: Opko Health Inc(OPK)

Advisors' Opinion:

• [By ]

  Opko Health (OPK) : "I've been waiting for these guys to come back on the show and tell us why we should buy."

  International Paper (IP) : "The stock is down big. I say at these prices it's a good buy."

• [By Keith Speights]

  If you're looking for stocks that have made tremendous comebacks in 2018, Opko Health (NASDAQ:OPK) and Myriad Genetics (NASDAQ:MYGN) definitely fit the bill. Opko stock was down nearly 20% this year before roaring back. Myriad Genetics saw its share price plunge close to 40% earlier in 2018, but a strong rebound has the stock price close to where it began the year.�

• [By Lisa Levin] Gainers Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday. ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings. TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday. TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results. Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent. Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results. OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat. Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday. KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings. New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results. Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings. Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Money Morning News Team]

  And after taking a look at our 10 top penny stocks to watch, we'll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq:�FB)…

  Penny Stock Current Share Price Law Week's Gain Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51% Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00% Opko Health Inc. (Nasdaq: OPK) $4.79 43.49% MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84% Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80% Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81% VAALCO Energy (NYSE: EGY) $1.49 36.04% Cel-Sci Corp. (NYSE: CVM) $3.16 35.04% WideOpenWest Inc. (NYSE: WOW) $8.41 34.52% Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

  While these gains are certainly exciting, it's important to recognize that investing in penny stocks is also a risky investment strategy.

Top Biotech Stocks To Buy For 2019: BlackBerry Limited(BBRY)

Advisors' Opinion:

• [By Shane Hupp]

  BlackBerry (TSE:BB) (NASDAQ:BBRY)‘s stock had its “in-line” rating reiterated by analysts at Imperial Capital in a report issued on Wednesday.

6 Most Important Things in Business Today

BMW posted solid financial results. According to MarketWatch:

Bayerische Motoren Werke AG said Thursday that its first-half sales rose 1.8% thanks to strong demand in Europe, the Americas and Asia.

The German premium auto maker said it sold 1.24 million cars in the first six months of the year, compared with 1.22 million a year earlier. Sales for June rose 2.7% to 238,920 units, the company said.

Broadcom Ltd. (NASDAQ: AVGO) will buy software operation CA Technologies. According to Reuters:

Broadcom Inc announced a $18.9 billion deal to buy U.S. business software company CA Inc on Wednesday, venturing far beyond its realm of semiconductors and testing investors�� confidence in its Chief Executive Hock Tan��s dealmaking credentials.

The CA deal, outlined in a joint statement from the companies, comes just four months after U.S. President Donald Trump blocked Broadcom��s $117 billion hostile bid for semiconductor peer Qualcomm Inc, arguing it posed a threat to U.S. national security and gave an edge to Chinese companies looking to build next-generation wireless networks.

Since then, Broadcom has redomiciled from Singapore to the United States, placing it formally outside the purview of the Committee on Foreign Investment in the United States (CFIUS), the government panel that reviews deals for potential national security risks.

Comcast Corp. (NASDAQ: CMCSA) increased its offer for U.K. media company Sky. According to The Wall Street Journal:

The battle for control of European pay-TV giant Sky PLC heated up Wednesday, with 21st Century Fox raising its bid and cable company Comcast Corp. quickly countering later in the day, the latest jockeying in a cross-Atlantic media deal showdown.

Comcast raised its offer for Sky to 拢14.75 per share, valuing the company at $34 billion. That is a 5% premium to an offer Fox announced earlier Wednesday and 18% above Comcast��s earlier bid. Comcast said its latest offer was recommended by Sky��s independent directors.

The founder of Papa John’s International Inc. (NASDAQ: PZZA) resigned after making racially charged comments. According to The Wall Street Journal:

Papa John��s International Inc. said late Wednesday that its independent directors have accepted the resignation of John Schnatter as board chairman, after a report that he used a racial slur in a conference call.

In a news release, the company said Olivia Kirtley will serve as lead independent director. Papa John��s will appoint a new chairman in the coming weeks.

Ford Motor Co. (NYSE: F) continues to take a beating in China:

Ford Motor Co. sales in China plunged 26% in the first half of 2018 compared with the same period last year, and there is little relief in sight as U.S.-China trade tensions worsen.

China��s auto market overall grew 5.6% in the first six months, with sales reaching 14.1 million vehicles, according to figures released Wednesday by the government-backed China Association of Automobile Manufacturers.

But Ford sold just 400,443 of those��the company��s poorest first-half showing in China since 2012. By comparison, General Motors Co. booked a record first-half performance in China, with sales increasing 4% to 1.84 million.

The International Energy Agency said oil production will be “stretched to the limit.” The organization’s experts wrote:

Some of these supply issues are likely to be resolved, but the large number of disruptions reminds us of the pressure on global oil supply. This will become an even bigger issue as rising production from Middle East Gulf countries and Russia, welcome though it is, comes at the expense of the world��s spare capacity cushion, which might be stretched to the limit.

Top 10 Small Cap Stocks To Invest In Right Now

tags:FCEL,PQ,CNR,ACHN,

In 2017, I want to stay with small cap companies but also go global, asserts fund expert Jim Lowell, editor of Fidelity Investor.

Recently, crossing the waters has been a recipe for higher volatility and lower returns.

But a sea change is affecting U.S. small caps for the better — a growing economy, a strengthening consumer, and trading with their neighbors rather than getting caught up in cross border currency wars.

These factors are also beginning to manifest themselves overseas — thanks to massive stimulus efforts underway in Europe and Japan.

My recommendation to play this trend is Fidelity International Small Cap Opportunities (FSCOX). Here, veteran multi-cap international stock picker Jed Weiss invests in small-cap companies from around the globe.

In this case, small-cap is defined as having a market-cap of $5 billion or less — so it's what the Street calls a "smid-cap" (small and mid cap) basket.

Top 10 Small Cap Stocks To Invest In Right Now: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:

• [By Paul Ausick]

  FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 43.9% in short interest during the period. Some 10.68 million shares were short as of June 29. The stock closed most recently at $1.33, down about 1.5% for the day, in a 52-week range of $1.29 to $2.49. Shares traded down more than 20% in the short interest period, and days to cover dropped from six to four.

• [By Peter Graham]

  Small cap fuel cell stock�FuelCell Energy Inc (NASDAQ: FCEL) reported Q4 and fiscal year ended October 31, 2017 earnings�with�Q4 total revenues�being $47.9 million versus $24.5 million:����

• [By Shane Hupp]

  FuelCell Energy (NASDAQ: FCEL) is one of 25 public companies in the “Miscellaneous electrical machinery, equipment, & supplies” industry, but how does it contrast to its peers? We will compare FuelCell Energy to related companies based on the strength of its risk, dividends, earnings, valuation, profitability, analyst recommendations and institutional ownership.

• [By Shane Hupp]

  Electro Scientific Industries (NASDAQ: ESIO) and FuelCell Energy (NASDAQ:FCEL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Top 10 Small Cap Stocks To Invest In Right Now: Petroquest Energy Inc(PQ)

Advisors' Opinion:

• [By Ethan Ryder]

  News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Small Cap Stocks To Invest In Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:

• [By Shane Hupp]

  Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

• [By Ethan Ryder]

  State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

• [By Stephan Byrd]

  Brokerages expect Canadian National Railway (NYSE:CNI) (TSE:CNR) to announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.10 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings of $1.00 per share in the same quarter last year, which would indicate a positive year over year growth rate of 3%. The business is scheduled to issue its next quarterly earnings report on Tuesday, July 24th.

Top 10 Small Cap Stocks To Invest In Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:

• [By Ethan Ryder]

  Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

• [By Stephan Byrd]

  Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints. MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday. Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday. Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday. Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday. Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday. Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec. Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading. Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session. LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported. Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire. HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

  Find out what's going

• [By Keith Speights]

  Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

Movers & Shakers: Volumes of Indoco Remedies & Thermax rose up to 19,000% in last 5 days

Moneycontrol News

The market is trading on a positive note this Tuesday afternoon with the Nifty up 94 points at 10,947 and the Sensex�gaining 333 points at 35,268.

Market breadth was strong with�1202 stocks advancing on the NSE,�520 declining, and 341 staying unchanged. On the other hand, in the BSE, 1665 stocks advanced and�972 declined and 139 were unchanged.

TCI Finance�has gained�30.54 percent�followed by�ITI�which gained 21.57 percent. These are�followed by�Banaras Beads�which added 21.49 percent while�Maan Aluminium�gained 20.96 percent.�Meghmani Organics�was up 18.77 percent.

Mentioned below are stocks that witnessed a surge in trading volumes on Tuesday compared to their 5-day average.

Indoco Remedies was trading with volumes of 626,938 shares, compared to its five day average of 3,213 shares, an increase of 19,410.11 percent. Thermax was trading with volumes of 256,678 shares, compared to its five day average of 1,398 shares, an increase of 18,265.63 percent.

Bhageria Industries was trading with volumes of 653,265 shares, compared to its five day average of 3,808 shares, an increase of 17,053.27 percent.

Somany Ceramics was trading with volumes of 178,315 shares, compared to its five day average of 2,019 shares, an increase of 8,731.85 percent.

Ashoka Buildcon was trading with volumes of 474,976 shares, compared to its five day average of 7,077 shares, an increase of 6,611.17 percent. First Published on Jul 10, 2018 03:35 pm

PetroDollar (XPD) Trading 0.8% Higher Over Last Week

PetroDollar (CURRENCY:XPD) traded down 5.1% against the US dollar during the twenty-four hour period ending at 21:00 PM Eastern on July 6th. Over the last week, PetroDollar has traded 0.8% higher against the US dollar. PetroDollar has a market cap of $470,643.00 and $406.00 worth of PetroDollar was traded on exchanges in the last day. One PetroDollar coin can currently be purchased for about $0.0074 or 0.00000112 BTC on major cryptocurrency exchanges including Cryptopia and YoBit.

Here’s how other cryptocurrencies have performed over the last day:

Get PetroDollar alerts: Altcoin (ALT) traded up 24.6% against the dollar and now trades at $22.64 or 0.00343891 BTC. Version (V) traded 1.5% higher against the dollar and now trades at $0.0022 or 0.00000033 BTC. UniCoin (UNIC) traded 4.8% lower against the dollar and now trades at $0.19 or 0.00002914 BTC. Prototanium (PR) traded up 20.9% against the dollar and now trades at $1.52 or 0.00023164 BTC. SproutsExtreme (SPEX) traded flat against the dollar and now trades at $0.0001 or 0.00000001 BTC. Jin Coin (JIN) traded flat against the dollar and now trades at $0.0166 or 0.00000249 BTC. AgrolifeCoin (AGLC) traded flat against the dollar and now trades at $0.0005 or 0.00000006 BTC. Magnetcoin (MAGN) traded 0.1% higher against the dollar and now trades at $0.0542 or 0.00000824 BTC.

PetroDollar Profile

PetroDollar (CRYPTO:XPD) is a coin. It launched on February 19th, 2014. PetroDollar’s total supply is 63,993,275 coins. PetroDollar’s official Twitter account is @thepetrodollar.

PetroDollar Coin Trading

PetroDollar can be bought or sold on the following cryptocurrency exchanges: Cryptopia and YoBit. It is usually not currently possible to buy alternative cryptocurrencies such as PetroDollar directly using US dollars. Investors seeking to acquire PetroDollar should first buy Bitcoin or Ethereum using an exchange that deals in US dollars such as Coinbase, Gemini or GDAX. Investors can then use their newly-acquired Bitcoin or Ethereum to buy PetroDollar using one of the aforementioned exchanges.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “XPDUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Yes Bank stock rallies 3% after SEBI approves launch of its mutual fund business

Shares of private sector lender Yes Bank rallied more than 3 percent intraday on Thursday as it received approval from capital market regulator SEBI to launch mutual fund business.

"...has received the final regulatory approval (Certificate of Registration) from the Securities & Exchange Board of India (SEBI) to commence the mutual fund business," the country's fourth largest private sector lender said in a statement.

This approval is subsequent to the Reserve Bank of India��s approval granted to the bank to sponsor a mutual fund followed by SEBI's in-principle approval received subsequently, it added.

"This strategic initiative will further complement Yes Bank's retail liabilities and wealth management strategy, and also allow YES Asset Management India (YAMIL) to build on the bank's ��DIGICAL�� distribution network to provide customers a seamless Investment and Banking experience," Rana Kapoor, Managing Director & CEO, Yes Bank said.

related news Biocon shares gain nearly 2% on EU GMP certification for Bengaluru facility Force Motors gains 4% post June sales data

The migration of this differentiated sectoral knowledge will allow YES Asset Management (India) Limited, a wholly owned subsidiary of Yes Bank, to launch fund offerings across the spectrum of both Debt & Equity markets over the next 6-12 months, the bank said.

The lender also recently received the final license from SEBI to launch its custodian of securities business. The bank will also be opening representative offices in London and Singapore as per recent approval from RBI, in addition to its presence in UAE through its representative office in Abu Dhabi.

At 10:21 hours IST, the stock price was quoting at Rs 344.80, up Rs 9.30, or 2.77 percent on the BSE. First Published on Jul 5, 2018 10:36 am

Navient Corp (NAVI) Given Average Rating of “Hold” by Analysts

Shares of Navient Corp (NASDAQ:NAVI) have received a consensus rating of “Hold” from the fourteen ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $16.72.

A number of analysts recently issued reports on the stock. BidaskClub upgraded shares of Navient from a “strong sell” rating to a “sell” rating in a research note on Friday, March 9th. Zacks Investment Research lowered shares of Navient from a “buy” rating to a “hold” rating in a research note on Tuesday, March 13th. ValuEngine lowered shares of Navient from a “hold” rating to a “sell” rating in a research note on Tuesday, June 12th. Wedbush upgraded shares of Navient from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $14.50 to $15.75 in a research note on Friday, June 1st. Finally, Compass Point upgraded shares of Navient from a “neutral” rating to a “buy” rating and set a $16.00 price target for the company in a research note on Wednesday, April 4th.

Get Navient alerts:

Hedge funds have recently added to or reduced their stakes in the business. Nomura Asset Management Co. Ltd. bought a new stake in Navient during the first quarter valued at $138,000. Stone Ridge Asset Management LLC bought a new stake in Navient during the fourth quarter valued at $141,000. First Allied Advisory Services Inc. bought a new stake in Navient during the fourth quarter valued at $148,000. Gotham Asset Management LLC bought a new stake in Navient during the fourth quarter valued at $154,000. Finally, Amundi Pioneer Asset Management Inc. bought a new stake in Navient during the fourth quarter valued at $155,000. Hedge funds and other institutional investors own 98.14% of the company’s stock.

Navient opened at $13.38 on Monday, according to Marketbeat Ratings. The company has a current ratio of 21.07, a quick ratio of 21.07 and a debt-to-equity ratio of 28.03. The stock has a market cap of $3.54 billion, a price-to-earnings ratio of 7.47, a PEG ratio of 1.19 and a beta of 2.20. Navient has a twelve month low of $11.48 and a twelve month high of $16.97.

Navient (NASDAQ:NAVI) last issued its quarterly earnings results on Tuesday, April 24th. The credit services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.02. The business had revenue of $329.00 million during the quarter, compared to analyst estimates of $313.00 million. Navient had a net margin of 6.43% and a return on equity of 13.91%. During the same quarter in the previous year, the firm earned $0.37 earnings per share. analysts predict that Navient will post 1.88 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, June 15th. Shareholders of record on Friday, June 1st were paid a dividend of $0.16 per share. The ex-dividend date was Thursday, May 31st. This represents a $0.64 annualized dividend and a yield of 4.78%. Navient’s payout ratio is 35.75%.

About Navient

Navient Corporation provides asset management and business processing services to education, health care, and government clients at the federal, state, and local levels in the United States. The company operates in three segments: Federal Family Education Loan Program (FFELP) Loans, Private Education Loans, and Business Services.

Valeant Pharmaceuticals Intl (VRX) Stock Rating Lowered by TD Securities

TD Securities cut shares of Valeant Pharmaceuticals Intl (NYSE:VRX) (TSE:VRX) from a buy rating to a hold rating in a research note published on Friday morning, Marketbeat.com reports. The brokerage currently has $24.00 target price on the specialty pharmaceutical company’s stock.

Other analysts also recently issued reports about the company. Cantor Fitzgerald set a $25.00 price objective on Valeant Pharmaceuticals Intl and gave the stock a buy rating in a research note on Wednesday, February 28th. Deutsche Bank raised Valeant Pharmaceuticals Intl from a hold rating to a buy rating and set a $18.00 price target for the company in a research report on Monday, March 5th. Jefferies Financial Group increased their price target on Valeant Pharmaceuticals Intl to $23.00 and gave the company a buy rating in a research report on Wednesday, May 9th. Mizuho raised Valeant Pharmaceuticals Intl from a neutral rating to a buy rating in a research report on Tuesday, May 15th. Finally, TheStreet downgraded Valeant Pharmaceuticals Intl from a c rating to a d+ rating in a research report on Friday, May 25th. Five equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of $20.54.

Get Valeant Pharmaceuticals Intl alerts:

Shares of Valeant Pharmaceuticals Intl opened at $24.27 on Friday, Marketbeat.com reports. The company has a market capitalization of $8.63 billion, a PE ratio of 6.34, a P/E/G ratio of 0.37 and a beta of -0.34. Valeant Pharmaceuticals Intl has a 52 week low of $10.94 and a 52 week high of $27.79. The company has a debt-to-equity ratio of 5.59, a current ratio of 1.18 and a quick ratio of 0.92.

Valeant Pharmaceuticals Intl (NYSE:VRX) (TSE:VRX) last issued its quarterly earnings data on Tuesday, May 8th. The specialty pharmaceutical company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.60 by $0.29. The firm had revenue of $2 billion during the quarter, compared to the consensus estimate of $1.95 billion. Valeant Pharmaceuticals Intl had a positive return on equity of 27.87% and a negative net margin of 10.65%. The company’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.79 earnings per share. equities research analysts predict that Valeant Pharmaceuticals Intl will post 3.33 earnings per share for the current fiscal year.

In other news, Director Schutter Richard U. De acquired 15,000 shares of Valeant Pharmaceuticals Intl stock in a transaction on Tuesday, May 15th. The stock was acquired at an average cost of $21.83 per share, with a total value of $327,450.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 5.87% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of the company. First Allied Advisory Services Inc. boosted its holdings in shares of Valeant Pharmaceuticals Intl by 33.6% in the first quarter. First Allied Advisory Services Inc. now owns 15,101 shares of the specialty pharmaceutical company’s stock worth $242,000 after acquiring an additional 3,800 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of Valeant Pharmaceuticals Intl by 189.4% in the first quarter. Envestnet Asset Management Inc. now owns 5,991 shares of the specialty pharmaceutical company’s stock worth $103,000 after acquiring an additional 3,921 shares during the period. Gabelli Funds LLC boosted its holdings in shares of Valeant Pharmaceuticals Intl by 3.5% in the first quarter. Gabelli Funds LLC now owns 117,088 shares of the specialty pharmaceutical company’s stock worth $1,864,000 after acquiring an additional 4,000 shares during the period. MML Investors Services LLC boosted its holdings in shares of Valeant Pharmaceuticals Intl by 15.5% in the fourth quarter. MML Investors Services LLC now owns 40,581 shares of the specialty pharmaceutical company’s stock worth $843,000 after acquiring an additional 5,431 shares during the period. Finally, Prime Capital Investment Advisors LLC bought a new position in shares of Valeant Pharmaceuticals Intl in the fourth quarter worth $142,000. 46.95% of the stock is owned by hedge funds and other institutional investors.

Valeant Pharmaceuticals Intl Company Profile

Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.

Sei Investments Co. Purchases 40,219 Shares of Cabot Corp (CBT)

Sei Investments Co. increased its position in shares of Cabot Corp (NYSE:CBT) by 137.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,527 shares of the specialty chemicals company’s stock after acquiring an additional 40,219 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Cabot worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Citizens Financial Group Inc RI acquired a new position in shares of Cabot during the 4th quarter valued at about $142,000. Quadrature Capital Ltd acquired a new position in shares of Cabot during the 4th quarter valued at about $219,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Cabot by 48.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,663 shares of the specialty chemicals company’s stock valued at $226,000 after acquiring an additional 1,194 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new position in shares of Cabot during the 1st quarter valued at about $247,000. Finally, Quantbot Technologies LP acquired a new position in Cabot in the first quarter valued at about $252,000. 85.56% of the stock is currently owned by hedge funds and other institutional investors.

Get Cabot alerts:

A number of research analysts have commented on CBT shares. ValuEngine cut shares of Cabot from a “buy” rating to a “hold” rating in a research report on Tuesday, March 20th. Loop Capital set a $80.00 target price on shares of Cabot and gave the company a “buy” rating in a research report on Monday, April 23rd. Robert W. Baird reaffirmed a “hold” rating and issued a $67.00 target price on shares of Cabot in a research report on Tuesday, April 17th. Zacks Investment Research raised shares of Cabot from a “hold” rating to a “buy” rating and set a $69.00 target price on the stock in a research report on Thursday, May 10th. Finally, TheStreet cut shares of Cabot from a “b-” rating to a “c” rating in a research report on Monday, May 7th. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Cabot has an average rating of “Buy” and an average target price of $72.00.

In other news, SVP Brian A. Berube sold 7,311 shares of the stock in a transaction dated Thursday, May 31st. The shares were sold at an average price of $60.30, for a total transaction of $440,853.30. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gottberg Friedrich Von sold 10,000 shares of the stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $61.23, for a total transaction of $612,300.00. Following the sale, the insider now directly owns 29,854 shares in the company, valued at approximately $1,827,960.42. The disclosure for this sale can be found here. Insiders have sold 228,901 shares of company stock worth $14,194,838 in the last three months. Corporate insiders own 2.20% of the company’s stock.

NYSE CBT opened at $63.33 on Tuesday. Cabot Corp has a 12 month low of $50.56 and a 12 month high of $68.63. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.07 and a current ratio of 1.67. The stock has a market capitalization of $3.95 billion, a price-to-earnings ratio of 18.46, a P/E/G ratio of 1.50 and a beta of 1.38.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, May 7th. The specialty chemicals company reported $1.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.04. The business had revenue of $818.00 million for the quarter, compared to analysts’ expectations of $746.30 million. Cabot had a negative net margin of 6.14% and a positive return on equity of 15.83%. The business’s quarterly revenue was up 20.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.87 earnings per share. analysts predict that Cabot Corp will post 4.11 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, June 8th. Stockholders of record on Friday, May 25th were given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.08%. The ex-dividend date was Thursday, May 24th. This is a boost from Cabot’s previous quarterly dividend of $0.32. Cabot’s dividend payout ratio is currently 38.48%.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods.

Ryman Hospitality Properties (RHP) Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC reduced its position in shares of Ryman Hospitality Properties (NYSE:RHP) by 2.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,939 shares of the real estate investment trust’s stock after selling 4,363 shares during the period. Neuberger Berman Group LLC owned about 0.30% of Ryman Hospitality Properties worth $12,078,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in RHP. Strs Ohio boosted its position in shares of Ryman Hospitality Properties by 2.8% during the fourth quarter. Strs Ohio now owns 70,033 shares of the real estate investment trust’s stock worth $4,833,000 after buying an additional 1,908 shares during the period. Northwestern Mutual Wealth Management Co. boosted its position in shares of Ryman Hospitality Properties by 17,389.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 13,817 shares of the real estate investment trust’s stock worth $954,000 after buying an additional 13,738 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Ryman Hospitality Properties by 19.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,500 shares of the real estate investment trust’s stock worth $311,000 after buying an additional 726 shares during the period. Parametrica Management Ltd purchased a new position in shares of Ryman Hospitality Properties during the fourth quarter worth $284,000. Finally, Quantitative Systematic Strategies LLC purchased a new position in shares of Ryman Hospitality Properties during the fourth quarter worth $400,000. Institutional investors and hedge funds own 86.63% of the company’s stock.

Get Ryman Hospitality Properties alerts:

Several research firms have recently commented on RHP. Citigroup upgraded Ryman Hospitality Properties from a “neutral” rating to a “buy” rating and set a $86.00 price target for the company in a research report on Friday, April 6th. ValuEngine upgraded Ryman Hospitality Properties from a “buy” rating to a “strong-buy” rating in a research report on Thursday, March 1st. Bank of America raised their price target on Ryman Hospitality Properties from $80.00 to $85.00 and gave the stock a “buy” rating in a research report on Monday, February 26th. Deutsche Bank raised their price target on Ryman Hospitality Properties from $81.00 to $83.00 and gave the stock a “buy” rating in a research report on Monday, February 26th. Finally, SunTrust Banks raised their price target on Ryman Hospitality Properties to $70.00 and gave the stock an “outperform” rating in a research report on Monday, February 26th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Ryman Hospitality Properties currently has a consensus rating of “Buy” and an average price target of $78.83.

In other Ryman Hospitality Properties news, EVP Bennett D. Westbrook sold 5,000 shares of Ryman Hospitality Properties stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $81.81, for a total transaction of $409,050.00. Following the completion of the sale, the executive vice president now directly owns 14,466 shares of the company’s stock, valued at approximately $1,183,463.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Colin V. Reed purchased 6,142 shares of the firm’s stock in a transaction on Tuesday, April 17th. The shares were acquired at an average cost of $79.34 per share, with a total value of $487,306.28. The disclosure for this purchase can be found here. Company insiders own 3.20% of the company’s stock.

Ryman Hospitality Properties opened at $82.58 on Tuesday, MarketBeat Ratings reports. The firm has a market capitalization of $4.23 billion, a P/E ratio of 14.85, a P/E/G ratio of 1.88 and a beta of 1.18. Ryman Hospitality Properties has a 12-month low of $57.78 and a 12-month high of $83.20. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 4.58.

Ryman Hospitality Properties (NYSE:RHP) last released its earnings results on Tuesday, May 1st. The real estate investment trust reported $0.53 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.66). The company had revenue of $288.40 million during the quarter, compared to analysts’ expectations of $283.46 million. Ryman Hospitality Properties had a net margin of 14.27% and a return on equity of 48.28%. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $1.22 earnings per share. equities research analysts predict that Ryman Hospitality Properties will post 5.91 earnings per share for the current year.

Ryman Hospitality Properties Company Profile

Ryman Hospitality Properties, Inc (NYSE:RHP) is a REIT for federal income tax purposes, specializing in group-oriented, destination hotel assets in urban and resort markets. The Company's owned assets include a network of four upscale, meetings-focused resorts totaling 7,811 rooms that are managed by lodging operator Marriott International, Inc under the Gaylord Hotels brand.

Want to see what other hedge funds are holding RHP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryman Hospitality Properties (NYSE:RHP).

U.K. Economy Barely Grows as Households Rein in Spending

U.K. consumer spending lost momentum in the first quarter and companies cut investment after severe weather swept the country.

Household spending rose just 0.2 percent, the weakest performance in more than three years, and business investment declined 0.2 percent as snowstorms kept shoppers at home and hit construction projects.

#lazy-img-328055166:before{padding-top:56.25%;}

Economic growth was left unrevised at 0.1 percent, the figures Friday showed, and the Office for National Statistics continued to maintain that the weather had little impact on the quarter on balance. However, that assessment was challenged this week by Bank of England Governor Mark Carney.

The BOE refrained from raising interest rates this month, leaving economists and investors puzzling over whether officials will now choose to hike in August.

Much depends on how quickly the economy rebounds and the evidence so far is mixed, with Brexit fears mounting and consumers only just emerging from a cost of living squeeze that has hit stores from Marks & Spencer to home- improvement chain B&Q.

Consumer spending rose 1.1 percent from a year earlier, the smallest increase since the start of 2012.

The quarterly fall in business investment was the first in more than a year and was driven by lower spending on non- residential buildings and vehicles, the ONS said. Construction output dropped by 2.7 percent.

GDP per head fell 0.1 percent, leaving growth from a year earlier at 0.6 percent, the weakest pace since 2012.

Services, the largest part of the economy, rose just 0.1 percent in March following a 0.3 percent decline in February. Growth in the first quarter was unrevised at 0.3 percent, with consumer-facing services experiencing a poor start to the year.

Trade had no impact on GDP growth, as exports fell 0.5 percent from the fourth quarter and imports declined 0.6 percent.

Britain is set to remain stuck in the economic slow lane again this year, with growth of around 1.4 percent trailing well behind Group of Seven peers Germany, France and the U.S.

— With assistance by Mark Evans

LISTEN TO ARTICLE 2:03 Share Share on Facebook Post to Twitter Send as an Email Print

Best Low Price Stocks To Buy Right Now

tags:BLRX,NUS,IMMU, Canadian plane maker Bombardier (BDRAF) scored a huge win in its ongoing trade dispute with Boeing.

The U.S. International Trade Commission voted unanimously Friday that Boeing (BA)was not harmed by Bombardier and its all-new C Series jet.

The vote effectively shelves two tariffs, totaling nearly 300%, that the U.S. Commerce Department wanted to impose on Bombardier.

Boeing, the American aerospace giant, claims Canada's Bombardier unfairly benefited from government bailout subsidies. Boeing says those funds allowed Bombardier to sell its new C Series airliner to Delta Air Lines (DAL) at "absurdly low prices" in violation of U.S. trade rules.

Delta in 2016 ordered up to 125 of the 110-seat C Series jets. Deliveries were expected to begin in spring 2018, but those plans are in question pending the outcome of the case.

While Boeing's claims of harm come as the Trump administration strikes an aggressive posture on trade, the ITC's appointees were all chosen by either Presidents Barack Obama or George W. Bush.

Best Low Price Stocks To Buy Right Now: BioLineRx Ltd.(BLRX)

Advisors' Opinion:

• [By Money Morning News Team]

  BioLine Rx Ltd.�(Nasdaq: BLRX) has the cheapest share price of the three stocks on this list.

  Currently trading at $1.16 per share, this Israel-based company focuses on developing therapeutics for a range of medical needs, including serious cardiac issues, liver fibrosis, pain management, cancer, and inflammatory bowel disease.

• [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. 21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82. Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87. HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50 Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62. Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11. Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33. Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55. Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday. Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results. Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13. Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19. Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance. ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating. Biolinerx Ltd/S ADR (NASDAQ: BLRX)
• [By Lisa Levin] Companies Reporting Before The Bell Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion. Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion. The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion. AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion. Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million. Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million. Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million. Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million. Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million. Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million. CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million. Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million. Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter. BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share. Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

   

• [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million. Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results. Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. 21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33. Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27. Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating. PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat. NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399. Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643. Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16. Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results. GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results. The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results. Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Best Low Price Stocks To Buy Right Now: Nu Skin Enterprises Inc.(NUS)

Advisors' Opinion:

• [By Shane Hupp]

  Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) reached a new 52-week high and low during trading on Wednesday . The company traded as low as $81.72 and last traded at $81.25, with a volume of 3382 shares traded. The stock had previously closed at $80.34.

• [By ]

  Nu Skin Enterprises (NYSE: NUS) is benefiting from two key trends: its strong presence in Asia where it books 79% of its revenue and leading brand awareness with millennials. The company has increased its dividend every year since 2001, now paying a 2% yield, and maintains a share repurchase program that returns excess cash to shareholders.

Best Low Price Stocks To Buy Right Now: Immunomedics, Inc.(IMMU)

Advisors' Opinion:

• [By Ethan Ryder]

  Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.

5 Cannabis Stocks That Have Been Outperforming

A slew of positive headlines in recent weeks seems to have turned the tide for cannabis. Between Senate Minority Leader Chuck Schumer announcing plans to introduce legislation that would decriminalize cannabis on a federal level, and Michigan adding recreational cannabis to its November ballot, things have been looking up for the industry.

Of course with a market as speculative as cannabis, there are always going to be outperformers and underperformers, regardless of the macro picture. That said, let’s take a look at some of the recent outperformers.

The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

iAthus Capital Holdings, Inc. (OTC: ITHUF)

Up 94 percent YTD

The cannabis dispensary operator saw a 615 percent increase in revenue in 2017 while also expanding its operations to New York and Florida, and investors have certainly rewarded the stock. On a technical basis, ITHUF has broken above $4 for the first time since it gapped down on February 2. Though the stock has seen some red days of late, the upward trend still appears to be intact.

GW Pharmaceuticals (NASDAQ: GWPH)

Up 18 percent YTD

Arguably the most well-known cannabis play, GWPH has exploded in the last month to all-time highs following a crossover to the upside on April 12. Though the trend came close to ending in early May, the fact that the two moving averages have not crossed over again tells us that the stock is still in an uptrend.

Innovative Industrial Properties, Inc. (NYSE: IIPR)

Up 3.5 percent YTD

Like a lot of cannabis stocks, IIPR sold off in January and February. Unlike most of them, it has gained back all its recent losses.

Though VantagePoint's two moving averages crossed over during the second week of May—indicating a downtrend—the two lines appear to have crossed over again, signalling the beginning of an uptrend. 

MedReleaf Corp.(OTC: MEDFF)

Up 0.7 percent YTD

Like the others on this list, cannabis producer MedReleaf was very strong the last three weeks of April. The stock looks to have hit some technical resistance around the $20 handle, but according to VantagePoint’s indicators, the uptrend is still alive thanks to a rising blue predicted moving average and mostly green Neural Index.

AmeriCann, Inc. (OTC: ACAN)

Flat YTD

Despite being flat in 2018, Americann has been in a strong uptrend since April 5, more than doubling in the six weeks since. Despite some red days sprinkled in, the uptrend has only gotten stronger according to VantagePoint

The cannabis sector is one of the most volatile sectors in the equities market, and a stream of upcoming legislation decisions promises even more volatility. This is not a sector for the faint of heart, and many cannabis plays still have to prove viable business models. But for some companies, there are trades to be made.

VantagePoint is a content partner of Benzinga. For a free live demo or market forecast, click here

good investments

tags:EQR,SHAK,AVT,LTEA,GLAD,TTEK,

Core Laboratories'�(NYSE:CLB) financial results continued their steady improvement in the first quarter. While the company faced some headwinds from seasonality that caused results to flatten out versus the fourth quarter of 2017, they were still much better than the year-ago period. That progression should continue for the foreseeable future given the increasingly optimistic outlook for the oil market.

Core Labs results: The raw numbers

Metric

Q1 2018

Q1 2017

Year-Over-Year Change

Revenue

$170.0 million

$156.6 million

8.6%

Adjusted net income

$25.2 million

$18.1 million

39.3%

Adjusted earnings per share

$0.57

good investments: Equity Residential(EQR)

Advisors' Opinion:

• [By Max Byerly]

  ING Groep NV increased its position in shares of Equity Residential (NYSE:EQR) by 7.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,617 shares of the real estate investment trust’s stock after acquiring an additional 2,676 shares during the period. ING Groep NV’s holdings in Equity Residential were worth $2,318,000 as of its most recent filing with the Securities and Exchange Commission.

• [By Stephan Byrd]

  Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Equity Residential (NYSE:EQR) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,723 shares of the real estate investment trust’s stock after buying an additional 827 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.05% of Equity Residential worth $12,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

good investments: Shake Shack, Inc.(SHAK)

Advisors' Opinion:

• [By Garrett Baldwin]
  Yesterday, the Fed Open Market Committee announced it would not raise interest rates this session. The central bank committee, which is in charge of monetary policy, said that inflation is rising and that the U.S. economy is getting better. Markets are now looking forward to the next meeting on June 12 for the U.S. Federal Reserve to bump rates higher for the second time in 2018. Shares of Tesla Inc. (Nasdaq: TSLA) slumped more than 4.5% after Tesla CEO Elon Musk held an highly unusual earnings call. After announcing that his firm burned through $700 million in cash during the quarter of 2018, Musk refused to take any more questions on the company's fiscal health, dismissing analysts' questions as "boring." Musk instead spent the rest of the quarterly call taking questions from a YouTuber named Gali Russell who had lobbied Musk on Twitter to let him partake in the earnings call. This morning, the U.S. Labor Department reported initial jobless claims rose by 2,000, to 211,000. Analysts had projected 225,000 for the week. The tightening U.S. labor market has now seen the total number of Americans receiving benefits fall to the lowest level since 1973. America's unemployment rate is sitting at 4.1%, the lowest figure in 17 years. Tomorrow, the Labor Department will release the April jobs report. Four Stocks to Watch Today: GPRO, SPOT, CI GoPro Inc. (Nasdaq: GPRO) will lead another busy day of earnings reports on Wall Street. The firm will report earnings after the bell Thursday. Wall Street expects that the tech firm is about to report a loss of -$0.40 per share on top of $175.40 billion in revenue. Here's a way to make a lot of money in a short time during earnings season. Spotify Technology SA�(NYSE: SPOT) did not have a very good first earnings report. Shares plunged more than 8% after the firm's music-streaming forecasts fell well short of expectations. During its earnings report, signals indicated that the firm's growth could slow despite news that its
• [By ]

  TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks from the floor of the New York Stock Exchange including Home Depot (HD) , Apple (AAPL) and Shake Shack (SHAK) .

• [By Daniel B. Kline]

  One popular "better burger" purveyor, Shake Shack (NYSE:SHAK), recently tried to take those changes a step further: At one of its New York locations, the chain went entirely cashless. Customers had the option of paying either through the Shake Shack mobile app or with plastic at an order-taking kiosk -- but there was nary a live cashier to be found.

• [By Jim Crumly]

  Two stocks made big moves after reporting earnings:�Pandora Media (NYSE:P) and Shake Shack (NYSE:SHAK) gave their investors reasons to celebrate this weekend.

• [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings. Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share. California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings. Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results. Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance. Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter. Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results. Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results. B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings. HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings. Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r

good investments: Avnet, Inc.(AVT)

Advisors' Opinion:

• [By Stephan Byrd]

  DekaBank Deutsche Girozentrale raised its stake in Avnet (NYSE:AVT) by 763.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,310 shares of the technology company’s stock after purchasing an additional 63,936 shares during the period. DekaBank Deutsche Girozentrale owned about 0.06% of Avnet worth $3,050,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

good investments: Long Island Iced Tea Corp. (LTEA)

Advisors' Opinion:

• [By Garrett Baldwin]

  William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

• [By ]

  5. Blockchain-Related Stocks
  Shorting blockchain-related stocks is an ideal way to not only short bitcoin but also short the entire cryptocurrency craze. Many such stocks exist, such as Riot Blockchain (Nasdaq: RIOT), Long Blockchain (Nasdaq: LTEA), and Longfin (Nasdaq: LFIN). Choose the one that you think is most overhyped and short away!

• [By ]

  Long Island Ice Tea changed its name to Long Blockchain (Nasdaq: LTEA), sending shares 200% higher. It remains to be seen how a beverage maker will create shareholder value from blockchain technology -- not that its investors care.�

good investments: Gladstone Capital Corporation(GLAD)

Advisors' Opinion:

• [By Taylor Cox]

  Investor Events

  Gladstone Capital Corporation (NASDAQ: GLAD) and Gladstone Investment Corporation (NASDAQ: GAIN) each holding an analyst/investor day Micron Technology, Inc (NASDAQ: MU) holding analyst/investor day Baxter International Inc (NYSE: BAX) investor conference

  Tuesday
  Notable Earnings

good investments: Tetra Tech Inc.(TTEK)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Tetra Tech (TTEK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Will The Cryptocurrency Bubble Burst?

Wherever you look to find out about bitcoin and other cryptocurrencies, you will find one of two major lines of thought. Either cryptocurrency is a bubble that is set to burst, or it is a perfect investment solution that will make you millions. The cryptocurrency landscape is actually, in reality, more likely to rest somewhere in the middle of these two extreme outcomes. Here we consider why the cryptocurrency market is not about to burst and why it is more likely to offer ongoing success, like the dot com boom did.    The bitcoin boom There is no doubt that cryptocurrency got out of hand at the end of 2017. When bitcoin crossed the threshold to become 1,000 percent more valuable in less than a year it was clear that the brakes needed to be applied, but the increase continued from there. For those who timed it perfectly, buying at $10,000 and cashing out at $19,000, cryptocurrency has already paid out. For many others, however, the drop from $19,000 to around $9,000 at present is one that will fill them with anxiety. With bitcoin doubling in value on a daily basis a crash or correction was inevitable, but the important take away is that bitcoin did not collapse completely. Instead, the cryptocurrency corrected itself in the same way that other currencies do, and it is still a valuable investment to hold.    The dot com moment Cryptocurrencies can currently be seen to be going through their dot com moment. In the 1990s the hype of the internet caused a bubble and a burst, but just as with bitcoin this did not spell the end of the internet. In the 1990s the future of the internet was uncertain and the future of bitcoin and other cryptocurrencies is uncertain too, but there are indicators that cryptocurrency is here to stay. While Silicon Valley felt the hit of the dot com crash, the internet came back bigger and better within a decade. While the give and take for speculators at the outset of the internet was painful for some, the new paradigm was inevitable in succeeding and being valuable.    The early days of cryptocurrency One key thing to remember with cryptocurrencies is that we are still experiencing the early stages. A new paradigm has arrived that has caused an inevitable reaction by regulators and investors alike. In these early stages speculators can take the rises with the falls, but as bitcoin has shown, the cryptocurrency has the ability to stabilise and succeed as the internet did. While there will be big winners and big losers at the outset, the result will be a stable and new form of investment that can bolster investment portfolios around the world.    Investment diversification Cryptocurrency is here to stay for the simple reason it offers a new investment platform and portfolio option for investors. Cryptocurrency offers a stable trading platform that allows the transcendence of different markets and can in effect make international trading cost free. By trading in cryptocurrencies, international transactions are freed from conversion rates and charges to change one currency to another, allowing people to build wealth on an international platform without incurring added costs. Just as the internet removed boundaries, cryptocurrency is now achieving the same result using financial transactions that operate outside of normal investment regulations.    Will the cryptocurrency bubble burst? Cryptocurrency is here to stay and it offers a new and exciting investment opportunity. While there will be early teething problems that may cause some speculators to lose out, it is clear that this new currency is likely to correct and stabilise as we have seen with bitcoin. Investing in cryptocurrency will see its dot com moment and rise with renewed strength on the other side.

American Assets Trust (AAT) Position Lifted by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of American Assets Trust (NYSE:AAT) by 10.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,227 shares of the real estate investment trust’s stock after buying an additional 3,890 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.09% of American Assets Trust worth $1,377,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of the stock. Xact Kapitalforvaltning AB acquired a new position in American Assets Trust during the fourth quarter valued at $272,000. William Blair Investment Management LLC increased its position in American Assets Trust by 25.8% in the 4th quarter. William Blair Investment Management LLC now owns 643,088 shares of the real estate investment trust’s stock worth $24,592,000 after purchasing an additional 131,940 shares during the last quarter. MetLife Investment Advisors LLC acquired a new position in American Assets Trust in the 4th quarter worth about $734,000. Millennium Management LLC increased its position in American Assets Trust by 147.7% in the 4th quarter. Millennium Management LLC now owns 381,837 shares of the real estate investment trust’s stock worth $14,601,000 after purchasing an additional 227,654 shares during the last quarter. Finally, Meadow Creek Investment Management LLC increased its position in American Assets Trust by 24.8% in the 4th quarter. Meadow Creek Investment Management LLC now owns 8,738 shares of the real estate investment trust’s stock worth $334,000 after purchasing an additional 1,734 shares during the last quarter. 95.78% of the stock is currently owned by hedge funds and other institutional investors.

Get American Assets Trust alerts:

AAT has been the topic of several research reports. Morgan Stanley raised American Assets Trust from an “equal” rating to a “weight” rating and set a $37.00 target price on the stock in a research report on Tuesday, March 27th. Zacks Investment Research lowered American Assets Trust from a “hold” rating to a “sell” rating in a research report on Friday, March 2nd. Royal Bank of Canada set a $44.00 target price on American Assets Trust and gave the stock a “buy” rating in a research report on Saturday, February 17th. ValuEngine lowered American Assets Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Finally, Mizuho raised American Assets Trust from a “neutral” rating to a “buy” rating and set a $44.00 target price on the stock in a research report on Thursday, February 22nd. Three research analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $41.00.

In related news, CEO Ernest S. Rady purchased 105,101 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was bought at an average price of $32.65 per share, for a total transaction of $3,431,547.65. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Ernest S. Rady purchased 64,775 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The shares were bought at an average price of $32.56 per share, with a total value of $2,109,074.00. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 1,028,993 shares of company stock valued at $33,775,312. 34.15% of the stock is currently owned by corporate insiders.

Shares of American Assets Trust opened at $34.08 on Friday, MarketBeat Ratings reports. The company has a current ratio of 2.17, a quick ratio of 2.17 and a debt-to-equity ratio of 1.55. American Assets Trust has a fifty-two week low of $30.62 and a fifty-two week high of $41.69. The stock has a market capitalization of $1.63 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 3.20 and a beta of 0.40.

American Assets Trust (NYSE:AAT) last issued its earnings results on Tuesday, May 1st. The real estate investment trust reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.16). The firm had revenue of $80.73 million during the quarter. American Assets Trust had a return on equity of 2.52% and a net margin of 6.60%. equities research analysts expect that American Assets Trust will post 2.05 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 28th. Stockholders of record on Thursday, June 14th will be paid a dividend of $0.27 per share. The ex-dividend date is Wednesday, June 13th. This represents a $1.08 annualized dividend and a dividend yield of 3.17%. American Assets Trust’s dividend payout ratio (DPR) is presently 56.25%.

American Assets Trust Profile

American Assets Trust, Inc (the ?company?) is a full service, vertically integrated and self-administered real estate investment trust, or REIT, headquartered in San Diego, California. The company has over 50 years of experience in acquiring, improving, developing and managing premier retail, office and residential properties throughout the United States in some of the nation's most dynamic, high-barrier-to-entry markets primarily in Southern California, Northern California, Oregon, Washington, Texas and Hawaii.